Related Experiment Videos
The Role of Embolic Protection in Carotid Stenting Progress in Cardiovascular Diseases (PCVD)
1Cardiovascular Division, University of Pennsylvania; Penn Cardiovascular Outcomes, Quality, and Evaluative Research Center, University of Pennsylvania.
Insights
Comparing distal filter embolic protection devices (f-EPD) and proximal embolic protection devices (p-EPD) for carotid artery stenting is challenging due to difficulties in defining embolic events and underpowered analyses. Further research into emerging techniques is warranted.
Area of Science:
- Cardiovascular Interventions
- Medical Device Technology
- Neurology
Background:
- Embolic protection devices (EPD) are mandated for carotid artery stenting (CAS) reimbursement by CMS.
- Two main EPD classes exist: distal filter (f-EPD) and proximal (p-EPD).
- Direct comparison of f-EPD versus p-EPD efficacy is hindered by methodological challenges.
Purpose of the Study:
- To highlight the difficulties in measuring the incremental benefit of different embolic protection device (EPD) strategies.
- To identify challenges in defining and detecting embolic events during carotid artery stenting (CAS).
- To underscore the need for further investigation into emerging EPD technologies.
Main Methods:
- Analysis of current challenges in comparing distal filter EPD (f-EPD) and proximal EPD (p-EPD).
- Discussion of limitations in defining embolic events using transcranial Doppler and diffusion-weighted MRI.
- Review of existing comparative studies and their statistical power limitations.
Main Results:
- Defining embolic events is problematic as imaging abnormalities may not correlate with clinical outcomes.
- f-EPD is used more frequently than p-EPD, complicating direct comparative analysis.
- Current comparative studies are underpowered to definitively establish the superiority of one EPD type.
Conclusions:
- Comparative effectiveness research between f-EPD and p-EPD faces significant hurdles.
- Accurate assessment of embolic events and robust clinical trial designs are crucial.
- Emerging techniques and technologies in EPDs require further investigation for improved patient outcomes in CAS.
Abstract:
Embolic protection device (EPD) use has become ubiquitous and is currently mandated by the Centers for Medicare and Medicaid (CMS) for reimbursement in conjunction with carotid artery stenting (CAS). There are two classes of EPD devices: distal filter EPD (f-EPD) and proximal EPD (p-EPD). Measuring the incremental benefit of one strategy over the other remains problematic for several reasons. The first lies in the difficulty of defining an embolic event as transcranial Doppler and diffusion-weighted magnetic resonance imaging abnormalities may not correlate with clinical events. Next, f-EPD is used more frequently than p-EPD making direct comparisons challenging, as analyses to this point have been underpowered. However, there are several promising emerging techniques and technologies that warrant further investigation.